ABSTRACT Objective: Recently, Mitchell et al. (Behav Res Ther, 46, 581-592, 2008) conducted a randomized controlled trial of an empirically supported treatment for bulimia nervosa (BN) delivered face-toface (FTF-CBT) or via telemedicine (TV-CBT). Results suggested that the TV-CBT and FTF-CBT were generally equivalent in effectiveness. The objective of the current study was to examine ratings of therapeutic alliance factors in TV-CBT and FTF-CBT.
Introduction
The treatment of psychiatric disorders with empirically supported treatments is an important advancement in mental health service delivery. As new treatments become validated, those in mental health are faced with the challenge of disseminating these new treatments. One particularly challenging issue in the dissemination of empirically supported treatments is providing treatment to people in areas with limited access to mental health professionals trained in the delivery of empirically supported treatments. In some cases, advancements in telecommunications have allowed for the availability of mental health services at remote locations where access was previously limited. The use of telecommunications technology to provide medical services and exchange medical information is referred to as telemedicine. 1 The delivery of mental health services via telemedicine has been described for a number of psychiatric disorders and problems. The use of telemedicine in psychiatry has been observed to have efficacy in diagnostic and management decisions. 2 Delivery of mental health services through telemedicine has been shown to be equivalent to traditional, in-person service delivery in the treatment of both children and adults with depression 3, 4 ; however, these studies did not use manual-based empirically supported treatments. In regard to telemedicine, relatively little information is available about the delivery of empirically supported treatments.
Recently, Mitchell et al. 5 demonstrated that delivering a manual-based empirically supported treatment for bulimia nervosa (BN) via telemedicine was generally as successful as delivering the treatment in person. In this study, 128 participants with either BN or eating disorder-not otherwise specified (EDNOS) who reported at least one binge eating or purging episode per week were randomized to 16 weeks of cognitive behavioral therapy (CBT) for BN delivered either face-to-face (FTF-CBT) or via telemedicine (TV-CBT). Results of this study indicated that FTF-CBT and TV-CBT were roughly comparable in regard to the primary outcome measures: binge eating and purging frequency at the end of treatment and at 3-and 12-month follow-up points. 5 The few observed differences between the FTF-CBT and TV-CBT conditions were generally of limited clinical significance. The authors stated that the results indicated that empirically supported treatments for specific disorders can be delivery effectively via telemedicine.
An important consideration in delivering psychotherapy via telemedicine is the effect that telemedicine delivery has on the therapeutic alliance. In a recent review of the use of telemedicine across various medical disciplines, Mair and Whitten 6 observed that all reviewed studies reported that patients were generally satisfied with the delivery of healthcare services via telemedicine; however, the authors identified the lack of examination of the quality of interactions between patients and providers using telemedicine as a notable deficit in the literature. Cook and Doyle 7 examined ratings of therapeutic alliance in a sample of individuals who received the equivalent of supportive counseling or psychotherapy for a variety of difficulties through a text-based (either e-mail or chat room) online therapy. The authors reported that ratings of alliance for online therapy were equal to or exceeded ratings for face-to-face therapy; however, these results are based on a small, nonrandomized sample. 7 The present study used data collected during Mitchell et al.'s 5 randomized trial of CBT for BN delivered either face-to-face or via telemedicine. The goal of the present study was to examine the extent to which treatment delivery method, either face-toface or via telemedicine, differentially affected ratings of therapeutic factors made by both those receiving treatment and those providing treatment.
Method
The present study was approved by the institutional review board of the University of North Dakota.
Participants
Patients. Characteristics of the individuals enrolled in this randomized trial have been described in a previous publication. 5 Please see Table 1 for a summary of sample characteristics. Randomization was stratified by ED diagnosis (either full BN or EDNOS resembling BN) and by antidepressant medication history (never/previous or current).
Therapists. Six doctoral-level psychologists provided CBT for BN in both conditions. All psychologists were experienced in the delivery of the empirically supported CBT for BN. Assessment. Eating disorder diagnosis was assessed using the Eating Disorder Examination, 8 and comorbid diagnoses were assessed using the Structured Clinical Interview for DSM-IV Patient Edition (SCID-P). 9 Both those enrolled in the treatment and those providing the treatment completed the Working Alliance Inventory (WAI). 10, 11 The WAI is a 36-item instrument in which respondent's rate aspects of their experiences in psychotherapy or counseling. The instrument has three subscales: task, goal, and bond. The task subscale contains items related to specific therapeutic techniques used during the session and other related technical details. The goals subscale contains items that assess the extent to which the patient and therapist agree on and work toward therapeutic goals. The bond subscale contains items relating to trust, empathy, and other constructs that contribute to the therapeutic bond. Each question is rated on 7-point Likert scale with ''never'' and ''always'' at opposing poles. Patient ratings of suitability of treatment and likelihood for success in treatment were obtained using a questionnaire developed specifically for the present study.
Procedure
The WAI was completed by patients and therapists at weeks 2, 8, and 16. The suitability of treatment and expectation of success measure was completed by patients at week 2. 
Results
Treatment intervention studies frequently contain large amounts of missing data. 12 For this reason, maximum likelihood (ML) imputation was used to impute missing data with the most likely ratings according to all other available data. Analyses were also conducted using data from treatment completers only and in a hierarchical linear model to establish convergence of results from different statistical approaches. Data analyzed after ML imputation is presented fully here. Results from all three perspectives were generally similar, and no conflicting results were produced. Finally, patient ratings of treatment suitability and likelihood for success in treatment were analyzed in separate analyses.
Ratings of WAI Factors
The results in this section are analyzed separately for patients and therapists using mixed model ANOVAs. Week of treatment and treatment delivery method are the within-subjects independent variable and between-subjects independent variable, respectively. Scores for task, bond, and goal from the WAI are dependent variables.
Data from 58 FTF-CBT and 58 TV-CBT cases were used in this analysis. The Greenhouse-Geisser correction was used in the following analyses. When patients made ratings of session adherence to therapeutic task, ratings increased significantly over time F (1.480 Table 2 for a summary of WAI Scales and their changes during the course of treatment, and see Table 3 for a summary of significant and nonsignificant results. 
Ratings of Suitability and Likelihood of Success
Analyses of patient ratings of their likelihood of success in treatment and treatment suitability were conducted using independent samples t-tests. Significant differences between those in the FTF-CBT condition and those in the TV-CBT condition were not observed on either measure.
Discussion
The goal of the present study was to examine the extent to which treatment delivery method, either face-to-face or via telemedicine, differentially affected ratings of therapeutic factors made by both those receiving treatment and those providing treatment. To that end, data collected from participants, both patients and therapists, at 2, 8, and 16 weeks of treatment was subjected to analysis assess the effects of treatment delivery method on factors associated with the therapeutic alliance.
The task subscale of the WAI contains items related to the technical details of therapy sessions including the therapeutic technique being used. Patients did not identify significant differences between FTF-CBT and TV-CBT; however, therapists identified significant differences between FTF-CBT and TV-CBT. Generally speaking, the results indicate that therapists made higher ratings (i.e., more positive ratings) of the technical details of their therapy sessions in FTF-CBT. Additional examination of ratings on the task subscale indicated that patients made higher ratings of the technical details of therapy as treatment progressed.
The goal subscale of the WAI contains items related to patient-therapist agreement of therapeutic goals and the extent to which they work toward these goals in therapy. Patients did not make significantly different ratings on the goal subscale between FTF-CBT and TV-CBT. Therapists, however, made significantly different ratings on the goal subscale between FTF-CBT and TV-CBT. As with ratings on the task subscale, therapist ratings on the goal subscale were higher, thus more positive, for FTF-CBT. Patients and therapists made significantly higher ratings on the goal subscale over time. Broadly, this indicates that both patients and therapists felt their agreement about therapeutic goals and working toward these goals increased significantly through treatment.
The bond subscale of the WAI contains items concerning empathy, trust, and other aspects of the therapeutic bond. For patients, ratings of bond were not significantly different between treatment delivery methods, and ratings of bond increased throughout treatment. For therapists, ratings on the bond subscale were significantly different between treatment delivery methods. Therapist ratings of bond favored FTF-CBT. For both therapists, ratings on the bond subscale increased significantly over time.
Taken together, this indicates that therapists tended to favor FTF-CBT over TV-CBT; however, patients did not seem to have a strong preference for either delivery method insofar as ratings of factors associated with the therapeutic alliance were concerned. This might suggest that patients were placing greater emphasis on the ''what'' of treatment delivery (i.e., the treatment itself) rather than the ''how'' (i.e., treatment delivery method). Additionally, patients did not make significantly different ratings on suitability of treatment or likelihood of success in treatment. This demonstrates that patients were equally comfortable with FTF-CBT and TV-CBT conditions and believed they could be equally successful between the conditions. An important strength of the present study is the inclusion of individuals in the EDNOS category with weekly binge eating or purging episodes. The inclusion of these individuals contributes to the generalizability of the results to clinical practice as those in clinical practice are more likely to encounter the EDNOS variants of BN than full-threshold BN. Additionally, this study used a relatively large sample-an important strength in any study of treatment outcome. A final notable strength is that the treatment in this study was provided by doctorallevel psychologists experienced in providing CBT for BN and highly trained assessors conducted initial assessments. An important limitation of the present study is the observed attrition rate. Participants left the study throughout the treatment delivery period (further information about study flow and participant attrition are available elsewhere 5 ). Statistically, the attrition rate was addressed by using the ML imputation. Although the attrition rate was higher than would be preferred, it is consistent with the attrition rate observed in other large randomized trials. Unfortunately, reasons for attrition were not assessed.
The findings of the present study provide further support for the delivery of an empirically supported treatment via telemedicine to the extent that patients do not rate therapeutic alliance factors significantly differently between the treatment delivery methods. The present study broadly demonstrated that those receiving the treatment did not tend to favor face-to-face delivery over delivery via telemedicine where therapeutic factors were concerned. Perhaps, most importantly, therapists seemed to favor face-to-face delivery over telemedicine delivery, at least in ratings of factors associated with the therapeutic alliance. This might suggest that additional therapist training may be needed improve comfort with telemedicine delivery. Bakke et al. 13 provided suggestions for the successful provision of empirically supported treatment via telemedicine. Therapist education about the effectiveness of telemedicine delivery of empirically supported treatments as well as information on patient perceptions of therapeutic alliance might also help to alleviate concerns over the delivery of psychotherapy or counseling via telemedicine.
Conclusion
From the perspective of those receiving the treatment, there are generally not significant differences between treatment delivery methods on ratings of adherence to therapeutic tasks, adherence to therapeutic goals, and therapeutic bond. Therapists identified greater differences between FTF-CBT and TV-CBT, possibly demonstrating some discomfort with or possible disbelief in treatment delivery via telemedicine compared to in person treatment delivery. Future study in this area should include the delivery of empirically supported treatments for other psychiatric disorders via telemedicine and traditional, face-to-face delivery to establish converging evidence supporting the use of telemedicine delivery for empirically supported treatments and the acceptability of telemedicine delivery to patients.
